merck

More merck stories

FDA Smackdown: Cervarix vs. Gardasil

The FDA is rushing to rubber stamp Gardasil, a cervical cancer vaccine, for women ages 27-45. Initially, the miracle HPV-preventer has been well received by its intended market — women…

Simcha | March 20, 2008 - 5:00 pm